Search

MIRATI THERAPEUTICS: EXECUTIVE ASSISTANT TO CHIEF OPERATING OFFICER

Mirati Therapeutics: Mirati Therapuetics, Inc. is a publicly traded targeted oncology company focused on developing a pipeline of oncology...

NANOSCALE PERFLUOROCARBON EXPEDIATES BONE FRACTURE HEALING THROUGH SELECTIVELY ACTIVATING OSTEOBLASTIC DIFFERENTIATION AND FUNCTIONS

Fracture incidence increases with ageing and other contingencies. However, the strategy of accelerating fracture repair in clinical...

 
 
 
Trump hails 'tremendous progress' on Covid-19 vaccine

TRUMP HAILS 'TREMENDOUS PROGRESS' ON COVID-19 VACCINE

President Donald Trump on Friday touted “tremendous progress” combating the coronavirus pandemic, saying development of therapeutics...

Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More

BIO ROUNDUP: RACE AND PHARMA, ASCO RECAP, WARP SPEED AHEAD & MORE

Race is not a topic that often comes up in pharmaceutical discussions but perhaps it should. Disease doesn't discriminate by race,...

 
 
 
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs

ATLAS VENTURE RAISES $400M FUND TO SEED ANOTHER NEW SET OF BIOTECHS

Another venture capital firm that backs biotechs has raised a multimillion-dollar fund-money the firm, Cambridge, MA-based Atlas Venture,...

Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline

CULLINAN ONCOLOGY REELS IN $98M TO ADVANCE CANCER DRUG PIPELINE

Cullinan Oncology emerged nearly three years ago with an approach to cancer drugs its founders said would improve the odds of success....

 
 
 
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs

PLIANT THERAPEUTICS PRICES IPO, LANDS $144M TO TEST FIBROSIS DRUGS

Pliant Therapeutics is now a public company, raising $144 million from its IPO, plus more from a separate transaction with partner...

NITTO BIOPHARMA INC.: SR. SCIENTIST, ANALYTICAL R\U0026D NBPI031

Nitto BioPharma Inc.: Demonstrated success conducting independent research in areas of analytical chemistry, nucleic acid therapeutics,...

 
 
 
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

CHINOOK, ADURO MERGER PLAN SETS UP NEW KIDNEY DISEASE-FOCUSED BIOTECH

Chinook Therapeutics and Aduro Biotech, each pursuing different approaches to the same rare disease, are now converging on a path to...

ELECTROPHARMACOLOGICAL CHARACTERIZATION OF ACICLOVIR IN THE HALOTHANE-ANESTHETIZED DOGS: A PROPOSAL OF EVALUATION METHOD FOR CARDIOVASCULAR SAFETY PHARMACOLOGY OF ANTI-VIRUS DRUGS

Abstract Given limited information regarding the pathophysiology underlying aciclovir-associated, clinically observed cardiovascular...

 
 
 

QUALIGEN THERAPEUTICS RELEASES FASTPACK® SARS-COV-2 ANTIBODY DIAGNOSTIC TEST TO UNIVERSITY OF LOUISVILLE TO CONDUCT VALIDATION STUDIES

CARLSBAD, Calif., June 2, 2020 /PRNewswire/ - Qualigen Therapeutics, Inc. announced today that the Company has released a pre-launch...

 
 
 

GOSSAMER BIO ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

SAN DIEGO--- $GOSS-Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and...

ASSOCIATE DIRECTOR/DIRECTOR OF CELL LINE DEVELOPMENT AND UPSTREAM PROCESS DEVELOPMENT - PHANES THERAPEUTICS INC - SAN DIEGO, CA

Design and carry out experiments and provide technical and operational leadership. Leadership skills in managing internal and external...

 
 
 

RESEARCH ASSOCIATE I - ASSAY DEVELOPMENT - SORRENTO THERAPEUTICS - SAN DIEGO, CA

Assay Development, QC Assay execution, and report generation. The Research Associate I will assist in daily lab projects that include...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

FORMA THERAPEUTICS EYES IPO TO ADVANCE SICKLE CELL, PROSTATE CANCER DRUGS

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational...

 
 
 
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

BIO ROUNDUP: ASCO OPENS, MERCK TAKES ON COVID, EVOFEM'S APPROVAL & MORE

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual...

 
 
 

PROFESSIONAL SALES REPRESENTATIVE - ESCONDIDO, CA - ASSERTIO THERAPEUTICS - ESCONDIDO, CA

Demonstrates account management sales execution based on creating product value to the prescriber, which includes customer satisfaction...

SORRENTO RECEIVES FDA IND CLEARANCE TO INITIATE A PHASE I CLINICAL TRIAL OF ITS CD38 ANTIBODY-DRUG CONJUGATE STI-6129 FOR PATIENTS WITH AMYLOIDOSIS

SAN DIEGO, May 26, 2020 - Sorrento Therapeutics, Inc. today announced it has received clearance from the U.S. Food and Drug Administration...